1,226 reports of this reaction
2.9% of all SOLIFENACIN SUCCINATE reports
#6 most reported adverse reaction
FALL is the #6 most commonly reported adverse reaction for SOLIFENACIN SUCCINATE, manufactured by Astellas Pharma US, Inc.. There are 1,226 FDA adverse event reports linking SOLIFENACIN SUCCINATE to FALL. This represents approximately 2.9% of all 42,941 adverse event reports for this drug.
Patients taking SOLIFENACIN SUCCINATE who experience fall should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FALL is a less commonly reported adverse event for SOLIFENACIN SUCCINATE, but still significant enough to appear in the safety profile.
In addition to fall, the following adverse reactions have been reported for SOLIFENACIN SUCCINATE:
The following drugs have also been linked to fall in FDA adverse event reports:
FALL has been reported as an adverse event in 1,226 FDA reports for SOLIFENACIN SUCCINATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
FALL accounts for approximately 2.9% of all adverse event reports for SOLIFENACIN SUCCINATE, making it a notable side effect.
If you experience fall while taking SOLIFENACIN SUCCINATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.